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The second messenger cGAMP synthesized by cGAS in virus-infected or cancer cells 
has the potential to activate STING in bystander cells. However, the underlying 
mechanism and physiological relevance of the cell-to-cell cGAMP transmission remain 
poorly understood. Here through a candidate screen, we found that chemical blockade 
or genetic ablation of volume-regulated anion channels (VRACs) composed of LRRC8 
heteromers resulted in defective IFN response to the DNA virus HSV-1, but not the 
RNA virus VSV. Biochemical and electrophysiological analyses revealed that 
LRRC8A/LRRC8E-containing VRACs transport cGAMP and cyclic dinucleotides 
across the plasma membrane. Enhancing VRAC activity by hypotonic cell swelling, 
cisplatin or GTPS, TNF or IL-1, increased STING-dependent IFN response to 
extracellular, but not intracellular cGAMP. Lrrc8e-/- mice displayed diminished IFN 
response and compromised host defense to HSV-1. Our findings reveal a crucial role 
for LRRC8 VRACs in cGAMP cell-to-cell transmission and suggest this transmission 


















The invasion and propagation of viruses and intracellular bacteria is frequently 
associated with the presence of double-stranded DNAs (dsDNAs) in the cytosol, which 
trigger diverse host defense mechanisms including the type I interferon (IFN) response  
(Chen et al., 2016b; Roers et al., 2016). The enzyme cyclic GMP-AMP synthase (cGAS) 
acts as sensor of cytosolic dsDNAs in infected and malignant cells (Sun et al., 2013). 
Upon binding to dsDNA, cGAS catalyzes the formation of 2’3’cGMP-AMP (cGAMP) 
(Ablasser et al., 2013a; Chen et al., 2016b; Wu et al., 2013), a second messenger that 
directly binds to the ER-anchored adaptor protein Stimulator of interferon genes 
(STING; also referred to as MITA or ERIS) (Ishikawa and Barber, 2008; Sun et al., 
2009; Zhong et al., 2008). Subsequently, STING triggers the activation of the kinase 
TBK1, which then phosphorylates the transcriptional factor IRF3 to induce a robust 
IFN response (Ablasser and Chen, 2019; Ablasser and Hur, 2020; Barber, 2015; Wu et 
al., 2013). cGAMP is uniquely produced in metazoans; however, other types of cyclic 
dinucleotides (CDNs) such as c-di-AMP (cdA), c-di-GMP (cdG) and 3’3’cGAMP, are 
produced by a wide array of prokaryotes and can also activate STING to elicit IFN 
responses (Danilchanka and Mekalanos, 2013; Margolis et al., 2017). cGAMP 
produced in virus-infected cells (Ablasser et al., 2013b) or cancer cells (Chen et al., 
2016a) can also be transmitted into bystander cells through gap-junctions, triggering an 
IFN response therein. cGAMP packaged into viral particles can be transferred into 
newly infected cells as well (Bridgeman et al., 2015; Gentili et al., 2015). Moreover, 
the folate transporter Slc19a1 has been implicated in the transport of extracellular 
cGAMP into the cytosol of a subset of human cells (Luteijn et al., 2019; Ritchie et al., 
2019).  
 
The volume-regulated anion channel (VRAC) controls cell volume by releasing Cl- and 
organic osmolytes in response to cell swelling (Hoffmann et al., 2009; Jentsch, 2016; 
Osei-Owusu et al., 2018; Pedersen et al., 2016), and consists of a heteromer of LRRC8 
proteins (Qiu et al., 2014; Voss et al., 2014). In addition to the obligatory subunit 
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LRRC8A (also known as SWELL1), at least one of the other LRRC8 isoforms 
(LRRC8B, -C, -D or -E) is needed to form hetero-multimeric channels in the plasma 
membrane (Voss et al., 2014). LRRC8 channels (VRACs) not only conduct Cl- and 
other halide ions, but also a variety of organic molecules. These include taurine (Qiu et 
al., 2014; Voss et al., 2014), inositol, glutamate and other neurotransmitters (Lutter et 
al., 2017; Yang et al., 2019), and therapeutic agents such as cisplatin and carboplatin 
(Planells-Cases et al., 2015) and blasticidin S (Lee et al., 2014). Whereas all LRRC8A-
containing heteromers yield swelling-activated Cl- currents, the transport of organic 
compounds depends on VRAC’s subunit composition. Inclusion of LRRC8D enhances 
the transport of all tested organic substrates (Lutter et al., 2017; Planells-Cases et al., 
2015), whereas inclusion of LRRC8E rather specifically stimulates the transport of the 
negatively charged glutamate and aspartate (Lutter et al., 2017). VRACs are thought to 
be important for diverse processes including insulin secretion (Best et al., 2010; Kang 
et al., 2018; Stuhlmann et al., 2018), neuron-glia interaction (Yang et al., 2019), stroke 
(Wilson et al., 2019; Yang et al., 2019), apoptosis and cancer drug resistance (Planells-
Cases et al., 2015), and sperm cell development (Luck et al., 2018). The importance of 
VRAC is further illustrated by the multiple tissue abnormalities and lethality of Lrrc8a-
deficient mice (Kumar et al., 2014; Platt et al., 2017). Besides activation by cell 
swelling, VRACs can be slowly opened by pro-apoptotic drug cisplatin (Planells-Cases 
et al., 2015), GTPS, and certain G-protein coupled receptors (Hoffmann et al., 2009; 
Nilius et al., 1999; Voets et al., 1998).  
 
Here we examined the roles of anion channels in anti-viral defense. A candidate screen 
revealed that inhibition of VRAC resulted in increased viral propagation upon HSV-1 
infection. Lrrc8a-/- cells exhibited higher viral loads after HSV-1 infection, but not VSV 
infection indicating a difference in responses to DNA versus RNA virus. The STING 
pathway activated by extracellular cGAMP was dampened in Lrrc8a-/- or Lrrc8e-/- cells 
and further biochemical analyses revealed transport of cGAMP and CDNs across the 
plasma membrane by VRACs containing LRRC8A and -E. Our findings suggest that 
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this transport is central to the host control of HSV-1 infection, likely through the 
induction of reinforcing IFN- synthesis in distant bystander cells. 
 
RESULTS 
LRRC8 VRACs Play a Crucial Role in Anti-viral IFN Response 
To explore the role of anion channels in anti-viral defense, we screened a small library 
of anion channel inhibitors using a cell-based viral infection platform modified from 
our previous study (Du et al., 2015). Infection with herpes simplex virus KOS strain 
(HSV-1) causes necrotic cell death in murine embryonic fibroblasts (MEFs) (Wang et 
al., 2014), a process often inversely correlated with IFN response. As proof-of-principle, 
Sting-/- MEFs underwent necrotic cell death following HSV-1 infection (Figure S1A). 
The screen revealed that 4-(2-Butyl-6,7-dichloro-2-cyclopentyl-indan-1-on-5-yl) 
oxobutyric acid (DCPIB) and carbenoxolone (CBX), two well-known VRAC inhibitors 
(Benfenati et al., 2009; Decher et al., 2001), augmented necrotic cell death (Figure 1A) 
and viral propagation (Figure S1B) following HSV-1 infection. Conversely, other anion 
channel blockers, including CaCCinh-A01, DIDS and glibenclamide, lacked a notable 
impact on HSV-1-induced cellular pathology (Figures 1A). Interestingly, treatment with 
DCPIB efficiently suppressed the IFN response to the DNA virus HSV-1 (Figures 1B 
and S1C), but had no significant impact on the induction of Ifnb and Cxcl10 by RNA 
virus vesicular stomatitis virus (VSV) (Figure 1C). These results suggested VRAC as a 
potential modulator of the IFN response to DNA virus.  
 
As DCPIB and CBX are non-specific VRAC inhibitors and can, for instance, also block 
other channels such as pannexin-1 and connexins (Ablasser et al., 2013b; Friard et al., 
2017), we employed a genetic approach to validate a role of VRAC in anti-viral IFN 
response. Whereas RNAi of Cx43 or Panx1 failed to affect the HSV-1-induced IFN 
response, RNAi of Lrrc8a severely compromised the induction of Ifnb and Cxcl10 
(Figure S1D). To rigorously examine the role of LRRC8 VRACs in anti-viral defense, 
we disrupted the obligatory Lrrc8a subunit in L929 mouse fibroblasts by Crispr-cas9 
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technology. Lrrc8a-/- L929 cells exhibited blunted expression of Ifnb and Cxcl10 at both 
mRNA (Figures 1D) and protein levels (Figure 1E). Following VSV infection, however, 
both wild-type (WT) and Lrrc8a-/- L929 cells elicited robust IFN response (Figure 1F) 
and exhibited a similar viral load (Figure 1G). Conversely, increased viral loads were 
associated with Lrrc8a-deficiency following HSV-1 infection (Figure 1G). Together, 
these results uncovered a role for LRRC8 VRACs in the IFN response for host defense 
against DNA viruses. 
 
LRRC8A/E-containing VRACs Promote Anti-viral IFN Response 
We next sought to extend the role of LRRC8A in anti-viral response to various primary 
cells. First, WT and Lrrc8a-/- MEFs (Figure 2A) were created by transduction of control 
or Cre-expressing retroviral vector to primary MEFs isolated from Lrrc8af/f mice (Yang 
et al., 2019). Upon HSV-1 infection, Lrrc8a-/- MEFs showed diminished expression of 
Ifnb and interferon stimulated genes (Isgs) Cxcl10 and Mx2 (Figure 2B). Moreover, 
Lrrc8a-/- MEFs produced less amounts of IFN- and CXCL-10 in response to HSV-1, 
but not VSV infection (Figure S2A). Next, WT and Lrrc8a-/- mouse lung fibroblasts 
(MLFs) and bone marrow-derived macrophages (BMDMs) were generated from 
tamoxifen-treated Lrrc8af/f and Lrrc8af/f:creERT mice, respectively. Upon HSV-1 infection, 
Lrrc8a-/- MLFs showed markedly reduced IFN responses (Figures 2C and S2B), which 
were correlated with increased expression of the HSV-1 encoded genes LAT and gB 
(Figure 2D). Likewise, Lrrc8a-/- BMDMs showed impaired Ifnb responses to HSV-1, 
but not to VSV infection (Figures 2E and S2C). Hence Lrrc8a participates in the anti-
HSV defense in a wide range of cell types, including immune and non-immune cells.  
 
Next, we generated mice deficient in each other subunit (Lrrc8b, Lrrc8c, Lrrc8d and 
Lrrc8e) to identify which one is needed, together with Lrrc8a, for anti-viral IFN 
response. Lrrc8e-deficiency markedly reduced HSV-1-triggered IFN response whereas 
deleting Lrrc8b, Lrrc8c or Lrrc8d lacked a significant impact (Figure 2C). Further, 
MLFs deficient in Lrrc8e, but not Lrrc8b-d, showed heightened viral replication upon 
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HSV-1 infection (Figure 2D). Furthermore, in BMDMs, Lrrc8e-deficiency 
compromised HSV-1-induced IFN response, particularly at lower MOI of viral 
infection (Figures 2F and S2D). Like Lrrc8a-/- BMDMs (Figure 2E), Lrrc8e-/- BMDMs 
displayed a normal IFN response to VSV infection (Figures 2F and S2D). Genetic 
deletion or RNAi of Lrrc8e in L929 cells also severely disrupted IFN responses to HSV-
1 infection (Figures S2E and S2F). Hence incorporation of the Lrrc8e subunit into the 
Lrrc8a-containing heteromeric VRACs is crucial for their role in anti-viral IFN 
response. 
 
LRRC8A/E-containing VRACs Enhance Extracellular cGAMP-induced STING 
Activation 
To understand how LRRC8A/E VRACs regulate anti-viral IFN responses, we examined 
the corresponding signaling in WT and VRAC-deficient cells. In WT MEFs, both HSV-
1 and VSV infection robustly activated TBK1 and IRF3 as evident from markedly 
increased phosphorylation, also STAT1 whose phosphorylation dependent on a 
feedback response by autocrine or paracrine IFN (Figures 3A and S3A). Lrrc8a-
ablation reduced the phosphorylation of TBK1, IRF3 and STAT1 upon infection with 
HSV-1, but not VSV in MEFs (Figures 3A and S3A). Because HSV-1 primarily engages 
the cGAS/STING pathway, whereas VSV predominantly acts through RIG-I/MAVS, 
we reasoned that LRRC8/VRACs might impinge on cGAS/STING signaling. However, 
directly activating cGAS by transfection of interferon stimulating DNA (ISD) triggered 
similar TBK1 and IRF3 activation in WT and Lrrc8a-/- (Figure 3B) or Lrrc8e-/- MEFs 
(Figure S3B). Likewise, transfecting cGAMP into the cytosol to directly activate 
STING resulted in similar phosphorylation of TBK1, IRF3 and STAT1 in WT and 
Lrrc8a-/- cells (Figure 3B). Hence, whereas VRACs are important for activating 
STING-dependent signaling upon HSV-1 infection, they do not influence the signaling 
events elicited by cytosolic agonists of cGAS or STING. Similar cGAMP production 
in WT and Lrrc8a-/- cells upon HSV-1 infection (Figure S3C) excluded a role for 




Given VRAC’s ability to transport metabolites and drugs, we wondered whether 
VRACs may transport cGAMP from infected cells to bystander cells where it may elicit 
an additional IFN response through STING. To indirectly measure cGAMP uptake 
though VRACs, we added cGAMP to culture media without transfection reagent and 
measured the induced IFN responses. Despite being hydrophilic and hence poorly 
permeable through lipid bilayers, extracellular cGAMP triggered marked 
phosphorylation of TBK1 and IRF3 in WT MEFs (Figure 3C). Similar effects were 
observed with extracellularly added bacterial cdA and 3’3’cGAMP (Figures 3C and 
S3D). Importantly, added cGAMPs and cdA induced much less phosphorylation on 
TBK1 and IRF3 in Lrrc8a-/- MEFs (Figures 3C and S3D). Also with MLFs, added 
cGAMP strongly induced Ifnb and Cxcl10 expression, but much less in Lrrc8a-/- cells 
(Figure 3D). Mirroring the roles of Lrrc8a and Lrrc8e in response to HSV-1 infection, 
ablation of Lrrc8e, but not of Lrrc8b, -c or -d, significantly reduced the IFN response 
to cGAMP extracellularly added to MLFs (Figure 3D). Lrrc8e-deficiency also impaired 
the secretion of CXCL-10 and CCL-5 in response to extracellular, but not to transfected 
cGAMP, nor to the cell permeable STING agonist DMXAA, LPS or polyI:C (Figure 
3E). Consistently, extracellular cGAMP induced less IFN- production in Lrrc8a-/- 
BMDMs (Figure 3F) or MLFs (Figure S3E). These results indicate that Lrrc8a/e-
containing VRACs may have a role in transporting cGAMP through the plasma 
membrane. 
 
The notion that Lrrc8e-containing VRACs mediate cGAMP transport was further 
buttressed by direct measurements of cellular cGAMP uptake using liquid 
chromatography-mass spectrometry (LC-MS) (Figure 3G). Ablation of either Lrrc8a or 
Lrrc8e, but not of Lrrc8b-d, decreased uptake of cGAMP into the cytosol by roughly 
60% (Figure 3G). Collectively, these data strongly suggest that Lrrc8e-containing 
VRACs may operate as a cell membrane conduit for cGAMP entry. With its larger size, 
extracellularly added FITC-conjugated cGAMP was unable to trigger Ifnb and Cxcl10 
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expression (Figure S3F) or induce IRF3 phosphorylation (Figure S3G), although it 
elicited robust TBK1/IRF3 phosphorylation when transfected with liposome (Figure 
S3H). 
 
The Response to Extracellular cGAMP Depends on VRAC Channel Activity 
If cGAMP permeates through VRAC’s ion conducting pore, the cellular effects of 
externally added cGAMP are expected to be similarly affected by procedures that block 
or enhance VRAC-mediated Cl- currents. Indeed, VRAC blockade with DCPIB or CBX 
diminished extracellular cGAMP-induced Ifnb and Cxcl10 expression in peritoneal 
macrophages (pMs) (Figure 4A) and MLFs (Figures 4B and 4C). Whereas DCPIB 
inhibited the uptake of extracellular cGAMP in WT cells by roughly 60%, it did not 
affect uptake into Lrrc8a-/- or Lrrc8e-/- cells (Figure 4D). Conversely, DCPIB lacked 
significant impact on IFN responses to LPS, polyI:C or IFN- (Figures S4A, S4B, and 
S4C). Hence, cellular effects of extracellular cGAMP are impaired when VRAC’s ion-
conducting pore is blocked.  
 
By contrast, GTPS and cisplatin, two agents capable of potentiating VRAC activity 
(Planells-Cases et al., 2015; Voets et al., 1998), markedly enhanced extracellular 
cGAMP-induced IFN response in MLFs, BMDMs and L929 cells (Figures 4E, 4F, and 
S4D). As expected, GTPS- or cisplatin-enhanced cGAMP response was abrogated in 
Lrrc8a-/- or Lrrc8e-/- cells (Figures 4E, 4F, and S4D). Strikingly, hypotonic cell swelling, 
the most potent stimulus for opening VRACs, greatly enhanced cGAMP-induced IFN 
responses in various mouse primary cells (MLF, pM and MEF) (Figures 4G, 4H, and 
S4E) and human cells (HeLa and THP-1) (Figures S4F and S4G). Collectively, these 
data strongly support the notion that cGAMP permeates VRAC’s pore.  
 
Hypotonic Activation of VRACs Enhances the Entry of Extracellular cGAMP 
While cell swelling robustly enhanced the IFN response to extracellular cGAMP, it 
failed to augment responses to intracellularly delivered cGAMP (Figure S5A). It neither 
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potentiated LPS-, polyI:C- or IFN--induced gene expression (Figures S5B and S5C). 
Cell swelling-promoted IFN responses to extracellular cGAMP were markedly reduced 
in Lrrc8a-/- L929 and MEFs (Figures 5A, 5B, and S4E), and in L929 or BMDM lacking 
Lrrc8e (Figures 5A and 5C). In contrast, Lrrc8b, -c, -d apparently lacked a significant 
role in cell swelling-promoted cGAMP response (Figure S5D). Likewise, RNAi of 
Panx1 or Cx43 did not affect the response to extracellular cGAMP in the setting of cell 
swelling (Figure S5E). 
 
In contrast to hypotonic swelling, exposure to hypertonic medium did not influence 
extracellular cGAMP-induced IFN response (Figure S5F). Hypotonicity-boosted Ifnb 
expression was abrogated by DCPIB, but not by glibenclamide or CaCCinh-A01, 
excluding the involvement of several other Cl- channels (Figure 5D). Cellular depletion 
of Cl- did not abolish the effect of hypotonicity on the extracellular cGAMP response, 
suggesting Cl- efflux is not required for cGAMP transport (Figure 5E). Cell swelling 
augmented extracellular cGAMP-elicited IRF3 phosphorylation, which was contingent 
on the expression of Lrrc8a or Lrrc8e in various cell types including MEF (Figure 5F), 
BMDM (Figure S5G), L929 (Figure S5H) and HeLa (Figure S5I).  
 
Under hypotonic condition, bacterial cdA, cdG and 3’3’cGAMP also induced robust 
IFN responses, which were severely diminished in Lrrc8e-RNAi cells (Figure 5G). 
Finally, we measured cGAMP entry by LC-MS in response to osmotic cell swelling. 
Hypotonicity profoundly enhanced cGAMP entry into cells (Figure 5H), a process that 
was strongly inhibited by DCPIB (Figure 5H) or genetic ablation of Lrrc8a or Lrrc8e 
(Figure 5I). Together, these data support a central role for Lrrc8e-containing VRACs in 
transporting cGAMPs and CDNs. 
 
LRRC8A/E-containing VRACs Transmit cGAMP to Bystander Cells 
Upon HSV-1 infection, cGAMP was detected in MEFs (Figure 6A), which were all 
viable (Figure S6A), and in the surrounding medium (Figure 6B), as quantified by LC-
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MS and more sensitive ELISA (Gentili et al., 2019), respectively. Heat-inactivated 
media from HSV-1-infected WT MEFs induced Ifnb expression in WT, but not Lrrc8a-
/- recipient cells, in a Sting-dependent but cGas-independent manner (Figure 6C). 
Preincubation with snake venom phosphodiesterase I (SVPDE), a cGAMP hydrolase 
(Ablasser et al., 2013b) abrogated the ability of culture media from HSV-1-infected cell 
to induce IFN response (Figure S6B). Media collected from HSV-1-infected Lrrc8a-/- 
cells showed less cGAMP (Figure 6B) or reduced capacity to trigger Ifnb than those 
from HSV-1-infected WT cells (Figure S6C), although their intracellular cGAMP 
productions were comparable (Figure S3C). Hence, VRAC probably mediates not only 
the uptake, but also the export of cGAMP.  
 
In addition to HSV-1, adenovirus (Lam et al., 2014) and murine cytomegalovirus 
(MCMV) (Bridgeman et al., 2015; Stempel et al., 2019) also engage the cGAS/STING 
pathway to mount IFN response. Both adenovirus and MCMV propagated more 
efficiently in Lrrc8a-/- MEFs than WT controls (Figure 6D), suggesting a more general 
role for VRAC in the host defense against DNA viruses. We then tested whether 
cGAMP produced by DNA virus-infected cells could activate STING in bystander cells, 
using the formation of perinuclear STING aggregates as read-out for STING activation 
by cGAMP (Ishikawa et al., 2009; Luo et al., 2016) (Figure S6D). We used adenovirus-
GFP to infect WT or Lrrc8a-/- MEFs that were transiently transfected with a STING-
cherry plasmid. After low MOI infection, cells infected with adenovirus-GFP exhibited 
prominent green fluorescence and STING-cherry aggregates (Figure 6E). STING-
cherry aggregates were also detected in uninfected cells identified by the absence of 
green fluorescence. These cells were often physically separated from infected cells 
(Figure 6E). In Lrrc8a-/- MEFs, STING aggregates were much less prominent in distant 
uninfected cells (Figure 6E). 
 
To further test whether cGAMP can be transmitted through VRACs from infected cells 
to bystander cells, we co-cultured HSV-1 pre-infected cells with uninfected bystander 
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WT or Lrrc8a-/- MEFs separated by a transwell filter for 6 h. We then measured the IFN 
response in the bystander cells. Remarkably, while physically separated, bystander WT, 
but not Lrrc8a-/- cells showed IFN induction (Figure 6F). While bystander IFN response 
was abolished in Sting-/- cells, a considerable induction of Ifnb was detected in Cgas-/- 
cells (Figure S6E). The moderate reduction in IFN response observed in Cgas-/- 
bystander cells (Figures S6E and 6C) might be attributable to an unexpected role of 
cGAS in the extracellular cGAMP response (Liu et al., 2019). Importantly, inclusion of 
DCPIB (Figure S6E) during the co-culture diminished IFN response in WT, but not 
Lrrc8a-/- recipients. Unlike HSV-1-infected cells, VSV-infected cells did not trigger 
significant Ifnb expression in transwell-separated bystander cells (Figure S6F). We also 
investigated the transmission of cGAMP from donor cells in which cGAMP synthesis 
was not stimulated by infection, but rather by transfection with DNA or overexpression 
of cGAS. These cells also induced marked Lrrc8a- and Sting-dependent IFN induction 
in bystander cells (Figure 6G). Hence, cGAMP can be transmitted to bystander cells to 
elicit a reinforcing IFN response. 
 
To test whether cGAMP can directly pass through VRAC channel pores, we performed 
whole-cell patch-clamp recordings. Intracellular Cl− was replaced with equal 
concentration of cGAMP2− as the only permeant anion and VRACs were activated by 
perfusion of hypotonic bath solution. The negatively charged cGAMP carried small but 
notable inward currents representing cGAMP2− efflux from WT HeLa (Figure 6H) and 
HCT116 (Figure S6G) cells. The leftward shifts in reversal potential indicated that the 
cGAMP permeability of VRAC is significant, although less than that of Cl− (estimated 
PcGAMP/PCl: ~0.1 assuming all intracellular cGAMP as free divalent anions) (Figure 6I). 
The cGAMP-mediated inward currents were abolished in LRRC8A-/- HeLa cells 
(Figures 6H, 6J, and 6K) and were blocked by DCPIB (Figure S6G). Notably, the 
VRAC Cl- currents were not blocked by extracellular 200 M cGAMP (Figure S6H). 




LRRC8A/E-containing VRACs Facilitate the Host Defense against HSV-1  
Contrasting with severely affected Lrrc8a-/- mice (Kumar et al., 2014), Lrrc8e-/- mice 
were viable and lacked an obvious phenotype. We intravenously infected Lrrc8e-/- mice 
and their control littermates with HSV-1. WT mice rapidly launched a robust IFN 
response, secreting large amounts of IFN-, CXCL-10, CCL-5, and TNF into the 
bloodstream 24 h post-infection (Figure 7A). In contrast, Lrrc8e-/- mice had severely 
compromised response to HSV-1 infection, showing marked reduction in IFN-, 
CXCL-10, CCL-5 and TNF (Figure 7A). Moreover, compared to WT mice, expression 
levels of Ifnb, Cxcl10 and Ccl5 were considerably lower in the lung and liver tissues of 
Lrrc8e-/- mice (Figure 7B). Viral gene expression was increased in multiple tissues of 
Lrrc8e-/- mice (Figure 7C), correlating with heightened viral loads in the liver and 
kidney of Lrrc8e-/- mice (Figure 7D). Consequently, Lrrc8e-/- mice displayed much 
more severe morbidity and greater weight loss than WT mice throughout the course of 
infection (Figure 7E). Notably, following VSV infection for 24 h, both WT and Lrrc8e-
/- mice produced similar amounts of IFN-, CXCL-10 and TNF in their sera (Figure 
S7A). We conclude that Lrrc8e-containing VRACs play a crucial role in host defense 
against DNA virus HSV-1 in vivo. 
 
Considering a crucial role for VRAC in anti-viral IFN response, we wondered whether 
VRAC-mediated cGAMP transmission could be enhanced by inflammation. We 
screened cytokines and growth factors for their ability to influence the IFN response to 
extracellular cGAMP. The cytokine TNF enhanced extracellular cGAMP-induced Ifnb 
expression in BMDMs (Figure S7B). Notably, TNF by itself neither raised intracellular 
cGAMP-induced Ifnb expression nor exerted a notable effect in Lrrc8a-/- BMDMs 
(Figure S7C). While being ineffective in BMDMs, IL-1 markedly increased 
extracellular cGAMP-induced response in MEFs, as did TNF (Figure S7D). IL-1’s 
effect likewise depended on the extracellular presence of cGAMP, and functional 
VRAC channels (Figures S7D and S7E). Measurement of cGAMP uptake confirmed 
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that TNF and IL-1 enhanced cGAMP transport through VRACs (Figure S7F), 
suggesting VRACs as both an effector and a propagator of inflammation.    
 
DISCUSSION 
Here we found that volume-regulated LRRC8 VRACs were critically involved in the 
host defense against DNA viral infection by transporting cGAMP across plasma 
membrane. Promotion of cGAMP-STING-dependent IFN responses in distant 
bystander cells may provide support to the infected cells. Our findings also suggest that 
cGAMP transmission through VRACs can be boosted by a diversity of stimuli 
including cell swelling, anti-cancer drugs and cytokines.  
 
The cGAS-STING pathway has the capacity to launch robust IFN responses, but highly 
pathogenic viruses often dampen or cripple this pathway. For example, HSV-encoded 
ICP27 can interfere with TBK1 activation and thereby prevent virus-infected cells from 
producing IFN response (Christensen et al., 2016). The host must evolve effective 
countermeasures, and bystander immune activation has emerged as an effective 
mechanism for thwarting viral immune evasion (Holmgren et al., 2017). cGAMP can 
be transported to neighboring cells via gap-junctions (Ablasser et al., 2013b) or Slc19a1 
(Luteijn et al., 2019; Ritchie et al., 2019). We discovered a role for VRACs as a conduit 
for transporting cGAMP into bystander cells in which it reinforces the STING-
dependent IFN response. Whereas gap-junctions only allow cGAMP transmission 
between physically connected cells, VRACs may facilitate the transfer of cGAMP into 
distant bystander cells, thereby reaching a larger number of cells. Only a subset of 
human cells exhibit Slc19a1-dependent cGAMP uptake, which was not seen in several 
mouse cell types tested (Luteijn et al., 2019). Likewise, we found that different cell 
types from both human and mouse exhibited variable VRAC-mediated cGAMP 
transport. Notably, while Lrrc8e-containing VRACs did not directly affect cGAMP 
production or cGAMP-triggered STING activation in virus-infected cells, ablation of 
Lrrc8e in mice resulted in compromised IFN response and ineffective defense against 
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HSV-1 infection, thus supporting the notion that cGAMP transmission to the bystander 
cells as an effective countermeasure to DNA viral infection. Ablation of Lrrc8a, which 
totally abolishes VRAC activity, inhibited cGAMP uptake by only ~50-70% in a wide 
range of cell lines and primary cells. The remainder may reflect the transport activity 
of the plasma membrane folate transporter Slc19a1 (Luteijn et al., 2019; Ritchie et al., 
2019), P2X7 purinergic receptors (Zhou et al., 2020) or yet to be identified transporters 
(Liu et al., 2019). LRRC8 VRACs may work in concert with these transporters to 
conduct cGAMP and CDNs in a cell type- and context-dependent manner.  
 
LRRC8 VRACs are largely, but probably not completely closed under resting 
conditions. Indeed, VRAC-mediated transport of cisplatin (Planells-Cases et al., 2015) 
or glutamate (Yang et al., 2019) can occur without opening VRAC with hypotonic 
swelling or other stimuli. We found that VRACs transported cGAMP also under resting 
conditions and that this transport could be stimulated further by hypotonic cell swelling, 
cisplatin or GTPS, or TNF or IL-1. Given that ROS-promoted cysteine oxidation can 
enhance LRRC8 VRACs (Gradogna et al., 2017; Varela et al., 2004), VRACs may be 
further activated during viral infection by factors such as TNF, IL-1 or ROS. VRACs 
transport a broad spectrum of small organic compounds contingent on their LRRC8 
subunit composition (Lee et al., 2014; Lutter et al., 2017; Planells-Cases et al., 2015). 
Whereas LRRC8A complexes with either one of LRRC8B-E to conduct Cl- efflux, 
inclusion of LRRC8D enabled the transport of all investigated organic compounds 
(Lutter et al., 2017). Our results indicate that LRRC8A/E-containing VRACs are 
particularly important for the transport of cGAMP and CDNs. Although the principles 
governing the substrate specificity of LRRC8 channels remain unclear, it is noteworthy 
that negatively charged aspartate could not only be transported by LRRC8D-containing 
VRACs, but also by VRACs containing LRRC8E or LRRC8C (Lutter et al., 2017; 
Schober et al., 2017). The fact that cGAMP is negatively charged points to a more 
general role of LRRC8E-containing VRACs in transporting negatively charged 
compounds. The relative expression of LRRC8B, -C, -D, -E, as well as cell-intrinsic 
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regulatory networks, likely influence cell type-specific roles of VRAC and the 
importance of specific LRRC8 subunits in cGAMP transport. 
 
Being channels, VRACs transport substrates by passive diffusion along their 
electrochemical gradients. Hence, they may mediate both cellular efflux and uptake of 
cGAMP. This concept is supported by our observation that more cGAMP was exported 
by HSV-infected WT cells than Lrrc8a-/- cells. The negative charges of cGAMP, 
together with the concentration gradient, would provide a driving force for cGAMP exit 
from cells. Likewise, under appropriate cGAMP concentration gradients, VRACs can 
mediate cGAMP uptake as demonstrated by equilibrium potential calculations (not 
shown). Conceivably, other mechanisms of cGAMP release might also come into play 
during HSV-1 infection, including Slc19a1 and RIPK3-MLKL-mediated formation of 
pro-necrotic pores (Su et al., 2014; Wang et al., 2014).  
 
The role of LRRC8 VRACs in immunity may extend well beyond infections with DNA 
viruses. Being capable of transporting bacterial CDNs, VRACs may also play a role in 
shaping immune responses against bacterial pathogens. Tumor-derived cGAMP can be 
transported into host cells, where it elicits IFN response to augment NK cell activation 
(Marcus et al., 2018). Hence, it is tempting to speculate that VRAC-mediated cGAMP 
efflux and/or influx might also have a role in these processes. Our work suggests that it 
might be worthwhile to test the role of VRACs in vaccination and explore the possibility 
of using VRAC agonists as co-adjuvant for cGAMP in cancer vaccine.  
 
In conclusion, we found a role for LRRC8/VRAC-mediated cGAMP transmission in 
host defense, likely by alerting distant bystander cells to trigger an effective anti-viral 
IFN response. The demonstration of an interplay between cell volume regulation and 
innate immune response and the cooperation among infected cells and non-infected 
cells in host defense may have profound implications in infection, cancer and vaccine 
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FIGURE LEGENDS 
Figure 1. VRAC Blockade Impairs HSV-induced IFN Responses.  
(A) MEFs pretreated with various chloride channel inhibitors (CaCCinh-A01 (15 µM), 
DIDS (60 µM), glibenclamide (30 µM), CBX (100 µM), DCPIB (20 µM)) were 
infected with HSV-1 (MOI: 0.01) for 36 h, and then fixed and stained with 0.5% crystal 
violet for 2 h.  
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(B, C) MEFs pretreated with 20 µM DCPIB were infected with HSV-1 (MOI: 0.01) (B) 
or VSV (MOI: 0.01) (C) for 12 h. RT-PCR was conducted to assess Ifnb and Cxcl10 
expression (n=3 biological replicates).  
(D-F) L929 cells were uninfected (UI) or infected with HSV-1 (D, E) or VSV (F) for 
12 h. The IFN responses were assessed by RT-PCR (D, F) or ELISA (E) (n=3 biological 
replicates).  
(G) L929 cells were uninfected or infected with HSV-1 (MOI: 0.1) or VSV (MOI: 0.01) 
for 24 h. The viral titers were measured by plaque assay (n=3 biological replicates).  
Data are presented as mean ± SEM (*p<0.05, **p<0.01, ***p<0.001, ns: not significant; 
analyzed by Student’s t test). 
See also Figure S1. 
 
Figure 2. LRRC8A/E-containing VRACs increase HSV-1-induced IFN responses. 
(A, B) Primary WT and Lrrc8a-/- MEFs confirmed by immunoblotting (A) were 
infected with HSV-1 for 9 h, and the expression of Ifnb and Cxcl10 were quantified by 
RT-PCR (B, n=3 biological replicates).  
(C, D) MLFs were uninfected or infected with HSV-1 (MOI: 0.5) for 9 h, and the 
expression of Ifnb and Isgs (C), as well as viral genes (D) were quantified by RT-PCR 
(n=3 biological replicates).  
(E, F) BMDMs were infected with HSV-1 or VSV (MOI: 0.1 for (E), and 0.1 or 1 for 
(F)) for 9 h, the expression of Ifnb was quantified by RT-PCR (n=3 biological replicates).  
Data are presented as mean  SEM (*p<0.05, **p<0.01, ***p<0.001 and ns: not 
significant; analyzed by Student’s t test). 
See also Figure S2. 
 
Figure 3. LRRC8A/E-containing VRACs Facilitate Extracellular cGAMP, but not 
Intracellular cGAMP-induced IFN Responses.  
(A-C) MEFs were treated with HSV-1 (MOI: 0.5) (A), cGAMP (2 μg/ml) or ISD (1 
μg/ml) transfected with lipofectamine 2000 (B), or cGAMP (10 μg/ml) or cdA (10 
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μg/ml) added to media (C) for 3 h. The activation of STING signaling was assessed by 
immunoblotting. Data are representative of four independent experiments. 
(D) MLFs were stimulated with added cGAMP (5 μg/ml) for 6 h. The expression of 
Ifnb and Cxcl10 was quantified by RT-PCR (n=3 biological replicates).  
(E) MLFs were stimulated with cGAMP (5 μg/ml), polyI:C (10 μg/ml), LPS (100 
ng/ml), DMXAA (5 M), or lipofectamine-transfected cGAMP (2 μg/ml) or polyI:C (1 
μg/ml) for 18 h. The secretion of chemokines was measured by ELISA (n=3 biological 
replicates).  
(F) BMDMs were treated with cGAMP (5 μg/ml) for 12 h, and the secreted IFN- was 
measured by ELISA (n=3 biological replicates).  
(G) MLFs were treated with cGAMP (2 μg/ml) for 1 h, and the cytosolic cGAMP was 
quantified by LC-MS (n=3 biological replicates).  
Data are presented as mean  SEM (*p<0.05, **p<0.01, ***p<0.001, ns: not significant; 
analyzed by Student’s t test). UT: untreated. 
See also Figure S3. 
 
Figure 4. VRAC Channel Activity Positively Correlates with Extracellular 
cGAMP Responses. 
(A) pMs were stimulated with 5 μg/ml cGAMP for 3 h in the presence of various 
amounts (5-80 µM) of DCPIB or 100 µM CBX. The expression of Ifnb was measured 
by RT-PCR (n=3 biological replicates).  
(B, C) MLFs were stimulated with 5 μg/ml cGAMP for 6 h w/ or w/o 5-10 (B) or 10 
(C) M DCPIB. The expression of Ifnb and Cxcl10 was measured by RT-PCR (B) or 
ELISA (C) (n=3 biological replicates).  
(D) MLFs were treated with cGAMP (5 μg/ml) for 1 h w or w/o 10 µM DCPIB. The 
cytosolic cGAMP was quantified by LC-MS (n=3 biological replicates).  
(E) MLFs were treated with 5 μg/ml cGAMP for 6 h in the presence of 50 µM cisplatin 
(CPT) or 20 µM DCPIB. The expression of Ifnb and Cxcl10 was measured by RT-PCR 
(n=3 biological replicates).  
 22 
 
(F) BMDMs were stimulated with 5 μg/ml cGAMP in the presence of 50 µM CPT or 
300 µM GTPγS for 6 h. The expression of Ifnb and Cxcl10 was measured by RT-PCR 
(n=3 biological replicates).  
(G) MLFs under isotonic or hypotonic conditions were stimulated with 5 μg/ml cGAMP 
for 3 h. The induction of Ifnb and Cxcl10 was analyzed by RT-PCR (n=3 biological 
replicates).  
(H) pMs under isotonic or hypotonic conditions were stimulated with cGAMP (1 or 5 
μg/ml) for 3 h. The induction of IFN response was measured by RT-PCR (n=3 
biological replicates).  
Data are presented as mean  SEM and analyzed by Student's t test (*p<0.05, **p<0.01, 
***p<0.001). UT: untreated; n.d.: not detected. 
See also Figure S4. 
 
Figure 5. Hypotonic Swelling Enhances VRAC Transport of cGAMP and CDNs. 
(A) L929 cells were stimulated with 5μg/ml cGAMP for 3 h under isotonic or hypotonic 
conditions. The induction of Ifnb and Cxcl10 was analyzed by RT-PCR (n=3 biological 
replicates).  
(B) L929 cells stimulated with 5 μg/ml cGAMP for 3 h under isotonic or hypotonic 
conditions were then cultured with normal media for another 12 h. The secretion of 
CXCL-10 was measured by ELISA (n=3 biological replicates).  
(C) BMDMs in isotonic or hypotonic buffer were stimulated with 5 μg/ml cGAMP for 
3 h. The induction of Ifnb and Cxcl10 was analyzed by RT-PCR (n=3 biological 
replicates).  
(D) MEFs were stimulated with 5 μg/ml cGAMP under isotonic or hypotonic conditions 
in the presence of various inhibitors (10-20 µM DCPIB; 2-10 µM CaCCinh-A01; 10-
40 µM glibenclamide). The induction of Ifnb expression was quantified by RT-PCR 
(n=3 biological replicates).  
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(E) MEFs were pretreated with low chloride isotonic buffer for 12 h, and then 
stimulated with 5 μg/ml cGAMP in low chloride isotonic or hypotonic buffer. The 
expression of Ifnb was quantified by RT-PCR (n=3 biological replicates).  
(F) MEFs were stimulated with 5 μg/ml cGAMP for 3 h under isotonic or hypotonic 
conditions. The signaling events were examined by immunoblotting. Data are 
representative of three independent experiments. 
(G) MEFs were stimulated with 5 μg/ml 3’3’cGAMP, 10 g/ml cdA or cdG for 3 h 
under hypotonic condition. The induction of Ifnb was analyzed by RT-PCR (n=3 
biological replicates). 
(H) MEFs were treated with 5 μg/ml cGAMP for 1 h under isotonic or hypotonic 
condition, and the cytosolic cGAMP was quantified by LC-MS (n=3 biological 
replicates).  
(I) MEFs were treated with 5 μg/ml cGAMP for 1 h under hypotonic condition w or 
w/o 10 M DCPIB. The cytosolic cGAMP was quantified by LC-MS (n=3 biological 
replicates). 
Data are presented as mean  SEM (* p<0.05, ** p<0.01, ***p<0.001; by Student's t 
test). UT: untreated; n.d.: not detected. 
See also Figure S5. 
 
Figure 6. LRRC8 VRACs Directly Transport cGAMP to Bystander Cells. 
(A, B) MEFs were infected with HSV-1 (MOI: 1-5 for (A), and 5 for (B)) for 3 h. The 
cytosolic cGAMP was quantified by LC-MS (A), and the extracellular cGAMP was 
quantified by ELISA (B) (n=3 biological replicates).  
(C) The supernatants from MEFs uninfected or infected with HSV-1 (MOI: 5) for 3 h 
were then incubated with uninfected recipient WT, Lrrc8a-/-, Sting-/-, or Cgas-/- MEFs 
for another 3 h. The induction of Ifnβ in the recipient MEFs was analyzed by RT-PCR 
(n=3 biological replicates).  
(D) WT and Lrrc8a-/- MEFs were infected with adenovirus-GFP (MOI: 0.01) or 
MCMV-GFP (MOI: 0.01) for 24 h, and the GFP-positive cells were visualized by a 
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fluorescence confocal microscope and quantified by Image J (n=4 biological replicates). 
(E) WT and Lrrc8a-/- MEFs transfected with STING-Cherry expressing plasmids for 12 
h were then infected with adenovirus-GFP (MOI: 0.01) for another 12 h (n=4 biological 
replicates). White arrows indicate STING aggregates in the uninfected cells, and yellow 
arrows indicate STING aggregates in the infected cells.  
(F) Sting-/- MEFs seeded on transwell chambers were infected with HSV-1 (MOI: 5) for 
3 h, and then co-cultured with WT or Lrrc8a-/- MEFs plated on 6-well plates for 6 h. 
The induction of Ifnβ and Mx2 in the recipient cells was analyzed by RT-PCR (n=3 
biological replicates).  
(G) Transwell seeded Sting-/- MEF cells and HEK293 cells were transfected with 
dsDNA for 3 h or a plasmid expressing cGAS for 12 h, respectively, then co-cultured 
with various genotypes of recipient MEFs for 9 h. The induction of Ifnβ in the recipient 
cells was analyzed by RT-PCR (n=3 biological replicates).  
(H) Hypotonicity (HYPO)-activated whole-cell currents from WT and LRRC8A-/- HeLa 
cells with Cl− based (50 mM NaCl) or cGAMP2- based (50 mM Na2cGAMP) 
intracellular pipette solution. Arrows indicate the reversal potentials.  
(I) Quantification of the reversal potentials of WT HeLa cells, n=9 cells for Cl− based 
recording, n=6 cells for cGAMP2- based recording. 
(J) Time-course of HYPO-activated whole-cell currents at −100 mV for WT and 
LRRC8A-/- HeLa cells with cGAMP2- based pipette solution.  
(K) Quantification of baseline subtracted HYPO-activated current densities at −100 mV 
in WT and LRRC8A-/- HeLa cells with cGAMP2- based pipette solution. n=6 for each 
group.  
Data are presented as mean ± SEM and analyzed by Student’s t tests, *p<0.05, ** 
p<0.01, *** p<0.001. UT: untreated; UI: uninfected. 
See also Figure S6. 
 
Figure 7. LRRC8A/E-containing VRACs Promote Host Defense to HSV-1. 
8-week-old WT and Lrrc8e-/- C57BL/6N littermates including both sexes were 
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intravenously infected with HSV-1 (1107 pfu/mouse).  
(A-C) The sera and tissues were collected in 24 h for ELISA (A) (n=10 mice) or RT-
PCR (B, C) (n=7 mice), respectively.  
(D) Plaque assay on tissues from HSV-1-infected mice for 24 h (n=4 mice).  
(E) Weight loss of HSV-1-infected mice recorded daily (n=10 mice for each genotype).  
Data analyzed by Student's t test (A-D) or two-tailed T test (E) are shown as mean  
SEM, and *p<0.05, **p<0.01, ***p<0.001. UI: uninfected. 




























Further information and requests for resources and reagents should be directed to and 
will be fulfilled by the Lead Contact, Hui Xiao (huixiao@ips.ac.cn). 
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10.17632/ss37r6d45n.1]. 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Mice 
All Lrrc8 VRAC-deficient mice were on C57BL/6N background, and both male and 
female littermates were used for all the experiments. Lrrc8a/Swell1f/f mice (on C57BL6 
background) were generated and described previously (Yang et al., 2019). Briefly, 
mouse embryonic stem (ES) cells bearing a floxed Lrrc8a allele from the European 
Conditional Mouse Mutagenesis Program (EUCOMM) were used to generate chimeric 
mice by blastocyst injection. Lrrc8af/f mice were bred onto Rosa26-creERT2 (B6/129) 
mouse strain (from Jackson Labs) to generate Lrrc8af/f:creERT mouse in this study. Lrrc8e-
/- mice were generated at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie 
(FMP), Berlin. Lrrc8b-/-, Lrrc8c-/-, Lrrc8d-/- and Lrrc8e-/- (STY-051) mice were 
generated by Biocytogen in Beijing, China using the sgRNAs listed in Table S1. The 
Sting-/- and Cgas-/- mice on C57B/6J background were from the Jackson Labs. All the 
mice were bred and maintained in a pathogen-free animal facility at Institut Pasteur of 
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Shanghai. All procedures were conducted in compliance with a protocol approved by 
the Institutional Animal Care and Use Committee at Institut Pasteur of Shanghai. 
 
Peritoneal Macrophages  
Peritoneal macrophages were isolated from 6- to 8-weeks-old C57BL/6J mice. 3 days 
after intraperitoneal injection of 2 ml of 3% thioglycollate medium (BD, Cat#: 211716), 
peritoneal macrophages were isolated and cultured in RPMI 1640 medium 
supplemented with 10% FBS (HyClone, Cat#: SH30084.03), 100 U/ml penicillin, and 
100 mg/ml streptomycin for use.  
 
Bone Marrow-derived Macrophages (BMDMs) 
Lrrc8af/f and Lrrc8af/f:creERT mice (6 weeks of age, sex-matched littermates on 
C57B6/129 background) were administered tamoxifen (Sigma-Aldrich, Cat#: T5648). 
2 mg of tamoxifen in 0.2 ml corn oil was delivered by intraperitoneal injection once 
every two days, and 3 times in total to induce the deletion of Lrrc8a. Primary BMDMs 
and MLFs were prepared 1 week after the last injection of tamoxifen.  
 
BMDMs were differentiated according to the method described previously (Deng et al., 
2015). Bone marrow cells from 8-10 weeks old WT and Lrrc8e-/- littermates were 
cultured in RPMI-1640 medium supplemented with 30% L929 conditioned medium 
and 10% FBS for 5-7 days before use.  
 
Mouse Lung Fibroblasts (MLFs) 
MLFs were prepared from Lrrc8af/f and Lrrc8af/f:creERT mice injected with 3 doses of 
tamoxifen as described above or from 8-10 weeks old WT and Lrrc8b-/-, Lrrc8c-/-, 
Lrrc8d-/- or Lrrc8e-/- littermates using a protocol described previously (Huaux et al., 
2003; Kono et al., 2007). Briefly, mouse lungs were cut into small pieces and digested 
with 0.1% collagenase D and trypsin in serum-free DMEM at 37°C for 1 h. Digested 
fibroblasts were centrifuged, washed, and then cultured in DMEM containing 10% FBS. 
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In 6-12 h, the nonadherent cells were washed off, and the adherent cells were cultured 
with DMEM containing 20% FBS, 100 U/ml penicillin and 100 mg/ml streptomycin 
for 5-10 days. 
 
Mouse Embryonic Fibroblasts (MEFs) 
MEFs were isolated as previously described (Lai et al., 2006). E14.5 embryos were 
digested overnight with 2 to 3 ml of ice-cold 0.25% trypsin-EDTA at 4°C. After 
vigorously pipetting, digested cells were dispersed and then spun down. After wash 
with PBS, embryonic cells were cultured in 10-cm dishes with DMEM containing 20% 
FBS, 100 U/ml penicillin and 100 mg/ml streptomycin for 5-7 days. When Lrrc8af/f 
MEF cells reached approximately 70 to 90% confluence, retroviral vectors pCDH or 
pCDH-Cre were transducted. Following puromycin-selection for 5 days, both WT and 
Lrrc8a-/- MEFs were obtained for experiments.  
 
Cell Culture  
Mouse fibroblasts L929, MEFs, HeLa and human HEK293T and HEK293 (from 
American Type Culture Collection) were cultured in DMEM (HyClone, Cat#: 
SH30243.01) supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/ml 
streptomycin. Human THP-1 cells (from American Type Culture Collection) were 
cultured in RPMI 1640 medium (HyClone, Cat#: SH30809.01) supplemented with 10% 
FBS, 2 mM L-Glutamine, 50 μM 2-mercaptoethanol, 1 mM pyruvic acid, 100 U/ml 
penicillin, and 100 mg/ml streptomycin. All cell lines were checked monthly for 
mycoplasma contamination by commercial PCR (Lonza Mycoalert Cat#: LT07-418). 
 
METHOD DETAILS 
LC-MS/MS Quantification of cGAMP 
Cellular cGAMP preparation was performed following previous protocols (Gao et al., 
2015; Wu et al., 2013). Briefly, HSV-1-infected or cGAMP-incubated cells were lysed 
in 1 ml of lysis buffer containing 80% of methanol and 2% of acetic acid pre-chilled to 
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80°C. After incubation for 5 min on ice, the lysates were centrifuged at 10,000 g for 10 
min, and the pellets were extracted with 0.5 ml of 2% acetic acid. The extracted cGAMP 
was enriched by Hyper Sep Aminopropyl SPE Columns (Thermo Scientific), and eluted 
with 1 ml of 4% ammonium hydroxide in 80% methanol. Following vacuum dry, the 
cGAMP was reconstituted in 40 μl of 50% acetonitrile and were ultrasonicated for 15 
min at room temperature. After centrifugation at 14,000 rpm for 15 min, the supernatant 
was collected for LC-MS/MS analysis. The LC-MS/MS analysis was performed on an 
Agilent 1290 UPLC (Agilent, USA) coupled to an AB Sciex 6500 Triple Quad mass 
spectrometer (AB Sciex, USA) with the electrospray ionization (ESI) source. A Waters 
ACQUITY UPLC BEH Amide column (1.7 µm, 2.1×100 mm) was used for GAMP 
separation with a flow rate at 0.4 ml/min and column temperature of 45°C. The mobile 
phases were comprised of (A) 0.2% formic acid and 10 mM Ammonium acetate in 50% 
acetonitrile and (B) 0.2% formic acid and 10 mM ammonium acetate in 95% 
acetonitrile. The gradient elution was 80% B kept for 1.0 min, then changed linearly to 
5% B during 7.0 min, increased to 80% B in 7.1 min and maintained for 2.9 min. The 
injection volume was set to 2 μL. The mass parameters were as follows: ion spray 
voltage was 5500 V, ion source temperature was 500°C, collision gas was Medium, ion 
source gas 1 was 50 psi, ion source gas 2 was 60 psi, curtain gas was 35 psi. Multiple 
Reaction Monitoring (MRM) was used to monitor GAMP in the positive ion mode. The 
proposed assay exhibits a good linear range of 2.5–500 ng/mL (2.5, 5, 10, 25, 50, 100, 
250 and 500 ng/mL) for GAMP, which sufficiently covers the typical levels determined 
in actual samples. 
 
Quantification of cGAMP by ELISA or Functional Assay 
MEFs of various genotypes (5104 cells in total) were seeded on a 48-well plate and 
infected with HSV-1 (MOI: 5) for 3 h. The supernatant was collected and cGAMP was 
measured by Cayman Chemical 2’3’-cGAMP ELISA Kit (Interchim, Cat#:501700) 




For extracellular cGAMP functional assay, 1107 MEF cells were infected with HSV-
1 (MOI: 5) for 3 h, and cell media were collected and centrifuged at 13,000 rpm for 10 
min. After discarding insoluble pellets, the supernatants were digested with 1000 U/ml 
of Benzonase at 37°C for 40 min in the presence or absence of 0.5U/ml of snake venom 
PDE (Sigma, isolated from Crotalus adamanteus) (Ablasser et al., 2013b; Bridgeman 
et al., 2015). Afterwards the supernatants were heated at 95°C for 10 min, followed by 
centrifugation at 13,000 rpm for 10 min, and then added to recipient MEFs of various 
genotypes for 3 h prior to RNA extraction and real-time PCR analysis of IFN response. 
 
ELISA Assay 
BMDMs, MEFs, and MLFs were infected with various MOIs of HSV-1 or VSV for 16-
24 h, or treated with 5-10 g/ml of 2’3’cGAMP for 12 h. The amounts of IFN-β, CXCL-
10, CCL-5 and TNF were assessed with ELISA kits according to the manufacturers’ 
recommendations (CCL-5 ELISA, peprotech Cat#: 900-K124; IP-10 ELISA, peprotech 
Cat#: 900-K153; IFN-β ELISA, Biolegend Cat#: 439407 and TNF ELISA, Systems 
from eBioscience. 
 
Hypotonicity-induced Cell Swelling 
Cells were incubated with isotonic buffer (110 mM mannitol, 90 mM NaCl, 2 mM KCl, 
1mM MgCl2, 1 mM CaCl2, and 10 mM HEPES, pH 7.4), hypotonic buffer (10 mM 
mannitol, 90 mM NaCl, 2 mM KCl, 1mM MgCl2, 1 mM CaCl2, and 10 mM HEPES, 
pH 7.4) or hypertonic buffer (220 mM mannitol, 90 mM NaCl, 2 mM KCl, 1mM MgCl2, 
1 mM CaCl2, and 10 mM HEPES, pH 7.4) for 3 h, in the absence or presence of cGAMP.  
 
For chloride-depletion, 90 mM sodium chloride in both isotonic and hypotonic buffer 





The upper cells, such as HEK293 cells (2.5105 per ml) transiently transfected with 
either empty vector or cGAS-expressing plasmid (4µg/ml) for 12 h, WT or Sting-/- 
MEFs transfected with dsDNA (8 µg/ml, lipofectamine) for 3 h, or WT or Sting-/- MEFs 
infected with HSV-1 (MOI: 5) for 3 h, were grown on a transwell (6-well Transwell 
with 0.4 µm pores from Corning, Cat# 3450) before co-culture with the recipient 
bystander cells. After transfection or infection, the culture media were removed, and 
the upper cells were washed 2-3 times with PBS prior to co-culture with the recipient 
cells. The recipient cells, including MEFs and MLFs of various genotypes (2105 per 
ml), were pre-seeded on 6-well culture plates, and grew separately until co-culture with 
various upper cells in the transwell chamber for another 6 h. In the case of DCPIB 
treatment, DCPIB (20 M) was added into the recipient cells 30 min before co-culture, 
and presented throughout the entire course of co-culture. Subsequently, the transwell 
chamber was removed and the recipient cells were collected for RNA preparation and 
RT-PCR analysis for IFN response. 
 
siRNA Design and Transfection  
siRNAs targeting Lrrc8a-e, Cx43, or Panx1 were ordered from GenePharma and listed 
in Table S1. SiRNAs were transfected to cells by Lipofectamine RNAiMAX 
Transfection Reagent (Thermo Fisher Cat#: 13778030) for 2-3 days before stimulation. 
 
Gene Targeting with CRISPR-Cas9 in L929 Cells 
SgRNAs against Lrrc8a or Lrrc8e were designed (https://www.genscript.com/gRNA-
design-tool.html) and listed in Table S1. The annealed sgRNA oligos were cloned into 
pLentiCRISPR plasmid (Addgene #78852), and packaged in HEK 293T cells. Viral 
media were harvested after 50 h. The Lenti-viruses-containing media were passed 
through a 0.45 m filter and added to L929 cells under selection with 1.5 mg/mL 
puromycin (Sigma Aldrich) for 1 week. and puromycin-resistant clones were screened 




RNA Preparation and Real-Time (RT)-PCR 
Total RNAs were extracted from L929, MEF and THP1 and peritoneal macrophages 
using TRIzol (Invitrogen, Cat#: 10296010) according to the manufacturer’s instruction. 
cDNA was reversely transcribed from 500 ng total RNA by PrimeScript RT-PCR kit 
(Takara, Cat#: RR014). RT-PCR was carried out with primer pairs listed in Table S1 on 
an ABI 7900HT Fast RT-PCR System. Data shown were the relative abundance of the 
indicated mRNA normalized to that of Gapdh by the change-in-cycling-threshold 
(∆∆CT) method.  
 
Viral Infection and Plaque Assay  
MEFs, L929 cells and MLFs (5105 per ml) were infected with HSV-1 or VSV in 
serum-free medium for 2 h as described previously (Ma et al., 2017). Afterwards, virus-
containing medium was removed and replaced with serum-containing DMEM medium. 
In 12 h post-infection, cells were harvested and RNAs were prepared by TRIzol. To 
check viral-induced cell death, 1.5 h after viral-infected, the supernatant was removed 
and cells were overlaid by 2×MEM containing 1.6% agar. 36 h post infection stained 
with 0.5% crystal violet dissolved in 4% formaldehyde for 2 h. Viral titers (pfu/ml) 
were calculated based on counted plaques.  
 
8-weeks old sex-matched littermates on C57BL/6N background were intravenously 
injected with HSV-1 (KOS strain, 1107 plaque-forming units PFU) and VSV (Indiana 
strain, 5 × 106 pfu) in 0.1 ml PBS (Ma et al., 2017), and the weight-loss of the infected 
mice was monitored daily up to 10 days. In 24 h post-infection, mouse sera were 
collected for ELISA, and the organs such as kidney, liver and spleen were removed and 
homogenized for RNA preparation and real-time PCR analyses.  
 
HSV-1 and VSV plaque assay was performed as described previously (Du et al., 2015; 
Ma et al., 2017). Briefly, the supernatants harvested from virus-infected cells were 
serial diluted in serum-free DMEM and then added into confluent Vero cells cultured 
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on 6-well plates. In 1 h, supernatants were removed and cells were overlaid by 4% 
methylcellulose. Three days later, the overlay medium was removed and cells were 
fixed with 4% formaldehyde for 1 h and then stained with 0.5% crystal violet. Viral 
titers (pfu/ml) were calculated based on counted plaques.  
 
Confocal Fluorescence Microscopy 
MEFs were transfected with pLVX-N-mCherry-hSTING by Lipofectamine 2000 
Transfection Reagent (Thermo Fisher, Cat#: 11668019) for 12 h. Subsequently, the 
liposomal/DNA-containing media were removed and transfected cells were infected 
with Adeno-virus-GFP (MOI: 0.01) or MCMV BAC pSMgfp (MOI: 0.01) for 24 h 
(Adeno-virus-GFP (Li et al., 2015) was kindly provided by Hongbin Ji from Institute 
of Biochemistry and Cell Biology, Shanghai, China; and MCMV BAC pSMgfp (Pan et 
al., 2018) was kindly provided by Zhikang Qian from Institut Pasteur of Shanghai, 
China). Next, the virus infected cells or cGAMP-treated cells were fixed with 4% 
paraformaldehyde for 10 min and stained with DAPI for 5 min at room temperature. 
The fluorescence images were collected on a laser capture confocal microscope 
(FV1200, Olympus) using separate laser excitation to avoid any cross-interference 
between different fluorophores. 
 
Electrophysiology  
Whole-cell patch-clamp recordings were performed as described previously (Yang et 
al., 2019). HeLa cells were plated onto coverslips 24-48 h before recording. For 
hypotonicity-activated VRAC current recordings, HeLa or HCT116 cells were whole-
cell patched in isotonic bath solution containing (in mM): 50 NaCl, 10 HEPES, 200 
mannitol (pH adjusted to pH 7.3 with NaOH and osmolality adjusted to 310 mOsm/kg), 
then hypotonic solution (HYPO) contains the same ionic composition but with only 100 
mannitol were applied. Recording pipettes were pulled by a micropipette puller (P-1000, 
Sutter instrument) and had a resistance of 5-10 MΩ when filled with the Cl− based 
intracellular solution containing (in mM): 50 NaCl, 10 HEPES, 200 mannitol (pH 
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adjusted to pH 7.3 with NaOH and osmolality adjusted to 310 mOsm/kg). cGAMP2− 
based intracellular solution was made by replacing 50 NaCl and 200 mannitol with 50 
Na2cGAMP (from ChemieTek) and 150 mannitol to maintain the same osmolality. 
Relative permeability of cGAMP2− to Cl− was estimated based on the reversal potential 
difference as described previously (Caldwell et al., 1986). The voltage ramp protocol 
(5 s or 15 s interval, 500 ms or 2.5 s duration) was used with a holding potential of 0 
mV and depolarized from −100 to +100 mV. Recordings were made with MultiClamp 
700B amplifier and 1550B digitizer (Molecular Device) or an EPC-10 amplifier. Data 
acquisition were performed with pClamp 10.7 (Molecular Device) or Patchmatser 
(HEKA) software, filtered at 1 kHz and digitized at 10 kHz. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
All data are shown as mean values, and error bars represent SEM from the number of 
assays indicated (from at least three independent experiments). For statistical 
comparisons, data were analyzed by an unpaired two-tailed Student’s t test (*p<0.05, 
**p<0.01, ***p<0.001; by Student's t test) to determine differences between groups 
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Figure S1 HSV-1-stimulated IFN- and CXCL-10 Production Depends on VRAC, Related to Figure 1
(A) WT and Sting-/- MEFs were uninfected (UI) or infected with HSV-1 (MOI: 0.01) for 36 h. Infected cells
were fixed and stained with 0.5% crystal violet for 2 h, and the images were collected by CTL immunospot
imager. Cell viability was quantified by Image J (cells positive-stained as blue were regarded as live cells).
(B) L929 cells were infected with HSV-1-GFP (MOI: 0.1) with or without 100 µM CBX or 20 µM DCPIB
for 36 h (n=3 biological replicates).
(C) L929 cells were infected with HSV-1 (MOI: 0.1) for 24 h with or without 100 µM CBX or 20 µM
DCPIB. CXCL-10 production was measured by ELISA (n=3 biological replicates).
(D) L929 cells transfected with various siRNAs for 48 h were then infected with HSV-1 (MOI: 0.1) for 12
h. The gene expression was quantified by RT-PCR (n=3 biological replicates).
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Figure S2 HSV-1-induced IFN Response Depends on Lrrc8e, Related to Figure 2
(A-C) MEFs, MLFs and BMDMs were infected with HSV-1 (MOI: 0.1) or VSV (0.01) for 18 h, and the
secreted IFN was assessed by ELISA (n=3 biological replicates).
(D) WT and Lrrc8e-/- BMDMs were infected with HSV-1 or VSV for 9 h, and the expression of Isgs was
quantified by RT-PCR (n=3 biological replicates).
(E) WT and Lrrc8e-/- L929 cells were infected with HSV-1 (MOI: 0.1) for 12 h. The expression of Ifnb
and Cxcl10 was quantified by RT-PCR (n=3 biological replicates).
(F) L929 cells transfected with control or Lrrc8e siRNAs for 48 h were infected with HSV-1 (MOI: 0.1).
The expression of Ifnb, Cxcl10 and Lrrc8e was quantified by RT-PCR (n=3 biological replicates).
Data are presented as mean  SEM (*p<0.05, **p<0.01, ***p<0.001 and ns: not significant; analyzed by
Student’s t test). UI: uninfected.
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Figure S3 Response to Intracellularly Applied cGAMP or Extracellular FITC-cGAMP Does Not
Depend on Lrrc8a or Lrrc8e, Related to Figure 3
(A) WT and Lrrc8a-/- MEFs were infected with VSV (MOI: 0.1), and the TBK1/IRF3 signaling was
assessed by immunoblotting. Data are representative of three independent experiments.
(B) WT and Lrrc8e-/- MEFs were transfected with 1 μg/ml ISD with lipofectamine for 3 h. Immunoblotting
was conducted for STING signaling. Data are representative of two independent experiments.
(C) The intracellular cGAMP from WT and Lrrc8a-/- MEFs infected with HSV-1 for 3 h was quantified by









(D) WT and Lrrc8a-/- MEFs were stimulated with 10 μg/ml 3’3’cGAMP added without transfection
reagent for 2 h. Data are representative of three independent experiments.
(E) WT and Lrrc8a-/- MLFs were stimulated with 5 μg/ml cGAMP for 12 h, and the supernatants were
collected for ELISA (n=3 biological replicates).
(F) WT and Lrrc8e-/- BMDMs were stimulated with 10 μg/ml cGAMP or FITC-cGAMP without
transfection for 3 h. The expression of Ifnb and Cxcl10 was quantified by RT-PCR (n=3 biological
replicates).
(G) WT and Lrrc8a-/- MEFs were incubated with 10 μg/ml cGAMP or FITC-cGAMP for 3 h. Data are
representative of two independent experiments.
(H) WT and Lrrc8a-/- MEFs were transfected with FITC-cGAMP (2 μg/ml) with Lipofectamine for 3 h.
Data are presented as mean  SEM (*p<0.05, **p<0.01, ***p<0.001 and ns: not significant; analyzed








Figure S4 Lrrc8/VRAC Augments Extracellular cGAMP Responses, Related to Figure 4
(A, B) peritoneal macrophages were stimulated with 100 ng/ml LPS (A) or transfected poly I:C (1
μg/ml) (B) for 3 h w or w/o 20 µM DCPIB. The induction of Cxcl10 and Mx2 was analyzed by RT-PCR
(n=3 biological replicates).
(C) L929 cells were stimulated by IFN-β (200 U/ml) for 3 h w or w/o 20 µM DCPIB. The induction of
Mx2 was analyzed by RT-PCR (n=3 biological replicates).
(D) WT and Lrrc8a-/- L929 cells were stimulated with 5 μg/ml cGAMP for 12 h in the absence or
presence of GTPS or cisplatin. The expression of Ifnb was measured by RT-PCR (n=3 biological
replicates).
(E-G) MEFs (E), HeLa (F) or PMA-differentiated THP-1 cells (G) under isotonic or hypotonic
conditions were stimulated with 5 μg/ml cGAMP for 3 h, gene expression was measured by RT-PCR
(n=3 biological replicates).
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Figure S5 VRAC-dependent Response to Extracellular cGAMP is Enhanced by Hypotonic Swelling,
Related to Figure 5
(A) L929 cells under isotonic or hypotonic conditions were liposome-transfected with 2 μg/ml cGAMP
for 3 h. The induction of Ifnb was analyzed by RT-PCR. (n=3 biological replicates)
(B, C) pMs under isotonic or hypotonic conditions were stimulated with LPS (100 ng/ml), polyI:C (30
g/ml) or IFN-β (200U/ml) for 3 h, the induction of Ifnb or Mx2 was analyzed by RT-PCR. (n=3
biological replicates)
(D, E) L929 cells transfected with control or gene-specific siRNAs for 48 h were stimulated with cGAMP
(5 μg/ml) for 3 h under hypotonic challenge. The gene expression was quantified by RT-PCR (n=3
biological replicates).
(F) L929 cells under isotonic, hypotonic or hypertonic conditions were stimulated with cGAMP (5 μg/ml)
for 3 h. The induction of Ifnb was analyzed by RT-PCR (n=3 biological replicates).
(G-I) BMDMs, L929 and HeLa cells were stimulated with added cGAMP (5 μg/ml) for 3 h under either
isotonic or hypotonic condition, the signaling events were examined by immunoblotting. Data are
representative of three independent experiments.










Figure S6 LRRC8A/E-containing VRACs Transport cGAMP, Related to Figure 6
(A) MEFs were infected with HSV-1 (MOI: 5) for 6 h, and released LDH (Lactate dehydrogenase) in the
media were measured by a LDH-Glo™ Cytotoxicity Assay kit. The media from MEFs treated with TNF
(10 ng/ml), Smac mimetic BV6 (0.5 M) and caspase inhibitor zVAD (20 M) for 8 h as a positive
control.
(B) Media from HSV-1-infected MEFs (MOI: 5, 6 h) digested with 0.5 U/ml SVPDE for 40 min were then
incubated with WT or Lrrc8a-/- recipient MEFs, and Ifnb in recipient MEFs was analyzed by RT-PCR.
(C) The media from HSV-1-infected WT or gene-ablated MEFs (MOI: 5) were incubated with uninfected
recipient WT MEFs for 3 h. The induction of Ifnβ in the recipient MEFs was analyzed by RT-PCR (n=3
biological replicates).
(D) WT and Lrrc8a-/- MEFs transiently transfected with plasmids expressing STING-Cherry for 18 h were
untreated (UT) or treated with 5 μg/ml cGAMP without transfection for 2 h. The STING aggregates were
quantified by an Image J software (n=2-8 biological replicates). Arrow indicates STING aggregates. UT:
untreated.
(E, F) Sting-/- MEFs on a transwell chamber were infected with HSV-1 (MOI: 5) (E) or VSV (MOI: 0.1)
(F) for 3 h, then co-cultured with various genotypes of recipient MLFs for 6 h w or w/o 20 M DCPIB.
The induction of Ifnβ in the recipient cells was analyzed by RT-PCR (n=3 biological replicates). UI:
uninfected.
(G) Data from HCT116 cells patched in the whole-cell configuration with a pipette solution containing (in 
mM) 50 Na2cGAMP (Invivogen), 130 mannitol, 20 EGTA, 10 HEPES, 4 MgATP, pH7.2 (NaOH). To 
elicit swelling-activated currents, cells were perfused with a 40% hypoosmotic bath solution containing 
(in mM) 82 NaCl, 6 CsCl, 1 MgCl2, 1.5 CaCl2, 10 glucose, 10 HEPES, pH 7.4 (NaOH), 200 mOsm/kg. 50 
µM DCPIB was used. Left, representative time course of currents (at -100 mV); right, currents at -100 mV. 
Because VRAC activation was monitored using a ramp protocol from -100 to +100 mV and chloride was 
present on the extracellular side, a minor contribution by chloride loaded during the ramp to the outward 
current cannot be excluded.
(H) While 50 µM DCPIB potently blocked VRAC currents and a low chloride solution induced a shift in 
the reversal potential, no effect of 200 µM cGAMP was observed. The recording pipette contained (in mM) 
140 CsCl, 20 EGTA, 10 HEPES, 4 MgATP, pH 7.2 (CsOH), 300 mOsm/kg. Na2cGAMP (Invivogen) was 
solubilized in the hypotonic recording solution on the day of experiments. Application of 200 µM cGAMP
was performed locally using the BioPen™ (Fluicell). To control for efficient solution delivery with this 
device, 50 µM DCPIB and a solution in which glutamate was substituted for chloride (low Cl-) were 
applied. Left, representative time course of currents (-100 and +100 mV). cGAMP, 200 µM; DCPIB, 50 
µM. Right, current relative to hypotonic control conditions. 










Figure S7 Proinflammatory Cytokines Enhance VRAC Activity and Bystander IFN Response,
Related to Figure 7
(A) 8-week-old WT and Lrrc8e−/− littermates (n=5 mice) were intravenously infected with VSV (5106
pfu/mouse). Sera were collected 24 h after infection for ELISA. UI: uninfected.
(B) BMDMs were treated with cGAMP (5 g/ml) for 6 h w or w/o cytokine as indicated, and RT-PCR was
conducted to assess Ifnb expression (n=3 technical replicates).
(C) BMDMs were treated with cGAMP (5 g/ml) or liposome-transfected (Tr-cGAMP) 2 g/ml cGAMP
for 6 h, and RT-PCR was conducted to assess Ifnb expression (n=3 biological replicates).
(D, E) MEFs were treated with cGAMP (5 g/ml) (D) or transfected 1g DNA (E) w or w/o 20 ng/ml IL-
1 or 20 ng/ml TNF for 3 h, and RT-PCR was conducted to assess Ifnb expression (n=3 biological
replicates). UT: untreated.
(F) MEFs were treated with 5 g/ml of cGAMP w or w/o 20 ng/ml IL-1 or TNF for 1 h in serum-free
media, and cytosolic cGAMP was measured by LC-MS (n=3 biological replicates).
Data are presented as mean  SEM. (*<0.05, ** p<0.01, *** p<0.001; ns: not significant, analyzed by
Student's t test).
Table S1. Oligonucleotides Used in This Paper, Related to STAR METHODS. 
Name Sequence (5'->3') 













Lrrc8a-siRNA-1-R ACAUAGUAGACGGUGUAGCTT  
Lrrc8a-siRNA-2-F CUCACUCCAUCUUUAGCCUTT  
Lrrc8a-siRNA-2-R AGGCUAAAGAUGGAGUGAGTT  
Lrrc8b-siRNA-F CUACACUACUUGGAUCUAATT  
Lrrc8b-siRNA-R UUAGAUCCAAGUAGUGUAGTT  
Lrrc8c-siRNA-F GCUGAUGAUCGGAGUGUUUTT  
Lrrc8c-siRNA-R AAACACUCCGAUCAUCAGCTT  
Lrrc8d-siRNA-F CUCAGAUGCUUAGACGUCATT  
Lrrc8d-siRNA-R UGACGUCUAAGCAUCUGAGTT  
Lrrc8e-siRNA-1-F GCUGACACAGAGGCCUUUATT  
Lrrc8e-siRNA-1-R UAAAGGCCUCUGUGUCAGCTT  
Lrrc8e-siRNA-2-F GGAGGAGGCGUGAAAGGUUTT  
Lrrc8e-siRNA-2-R AACCUUUCACGCCUCCUCCTT  
hLRRC8A-siRNA-F GCUUGCCUCUUCAGUAUUUTT  


















Lrrc8c-R GTTGGTCGGTGAGGGTTTAGGT   
Lrrc8d-F TCCCGCCTCCGCCTAAG 
Lrrc8d-R TGCGACGCGAGACTTCA 
























hIL6-F CAGACAGCCACTCACCTCTTCA  
hIL6-R CCTCTTTGCTGCTTTCACACAT 
 
 
 
 
 
